| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Helicases | 12 | 2024 | 51 | 5.830 |
Why?
|
| Transcription Factors | 14 | 2024 | 512 | 4.620 |
Why?
|
| Endothelial Cells | 15 | 2024 | 331 | 4.530 |
Why?
|
| Neovascularization, Physiologic | 13 | 2021 | 123 | 3.730 |
Why?
|
| Nuclear Proteins | 9 | 2024 | 245 | 3.660 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2021 | 18 | 2.800 |
Why?
|
| Blood Vessels | 9 | 2022 | 58 | 2.630 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2024 | 121 | 2.420 |
Why?
|
| Embryo, Mammalian | 7 | 2020 | 29 | 2.090 |
Why?
|
| Mice | 30 | 2024 | 4470 | 1.600 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2024 | 20 | 1.600 |
Why?
|
| Liver | 4 | 2018 | 423 | 1.430 |
Why?
|
| Lymphatic Vessels | 3 | 2022 | 20 | 1.410 |
Why?
|
| Animals | 34 | 2024 | 10073 | 1.320 |
Why?
|
| Capillaries | 3 | 2019 | 32 | 1.290 |
Why?
|
| Fibrinolysin | 3 | 2018 | 15 | 1.260 |
Why?
|
| Chromatin | 4 | 2019 | 74 | 1.240 |
Why?
|
| Signal Transduction | 9 | 2024 | 1377 | 1.110 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 3 | 2022 | 12 | 0.960 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2023 | 10 | 0.940 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 42 | 0.940 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 1496 | 0.860 |
Why?
|
| Cells, Cultured | 11 | 2024 | 976 | 0.850 |
Why?
|
| Atherosclerosis | 2 | 2024 | 95 | 0.840 |
Why?
|
| DNA-Binding Proteins | 4 | 2024 | 481 | 0.840 |
Why?
|
| Communicable Diseases | 1 | 2023 | 19 | 0.840 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2021 | 55 | 0.830 |
Why?
|
| Mice, Knockout | 10 | 2024 | 794 | 0.810 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 626 | 0.800 |
Why?
|
| Omentum | 1 | 2022 | 4 | 0.790 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2021 | 7 | 0.760 |
Why?
|
| Lung | 1 | 2024 | 363 | 0.750 |
Why?
|
| Wnt Proteins | 2 | 2012 | 32 | 0.750 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 145 | 0.740 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 7 | 0.720 |
Why?
|
| Oncogene Proteins | 1 | 2020 | 21 | 0.720 |
Why?
|
| Eye | 1 | 2020 | 35 | 0.710 |
Why?
|
| NF-kappa B | 1 | 2021 | 187 | 0.700 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 93 | 0.690 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 400 | 0.670 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 8 | 0.660 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2017 | 58 | 0.630 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 111 | 0.630 |
Why?
|
| Acetaminophen | 1 | 2018 | 11 | 0.620 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 278 | 0.620 |
Why?
|
| Drug Overdose | 1 | 2018 | 10 | 0.620 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 8 | 0.620 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2018 | 23 | 0.610 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 489 | 0.610 |
Why?
|
| GATA4 Transcription Factor | 1 | 2017 | 1 | 0.560 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 1405 | 0.550 |
Why?
|
| Yolk Sac | 4 | 2012 | 5 | 0.550 |
Why?
|
| Trans-Activators | 1 | 2017 | 114 | 0.550 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2023 | 50 | 0.540 |
Why?
|
| Cell Line | 5 | 2021 | 681 | 0.510 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 440 | 0.500 |
Why?
|
| Macrophages | 3 | 2024 | 279 | 0.490 |
Why?
|
| Embryonic Development | 3 | 2014 | 21 | 0.470 |
Why?
|
| Proteolysis | 1 | 2013 | 55 | 0.440 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 1 | 0.430 |
Why?
|
| Body Patterning | 1 | 2013 | 7 | 0.420 |
Why?
|
| Macular Degeneration | 2 | 2024 | 79 | 0.420 |
Why?
|
| Vesicular Transport Proteins | 4 | 2006 | 33 | 0.420 |
Why?
|
| Veins | 1 | 2013 | 19 | 0.420 |
Why?
|
| Neovascularization, Pathologic | 4 | 2021 | 144 | 0.420 |
Why?
|
| Phenotype | 4 | 2024 | 666 | 0.380 |
Why?
|
| Endothelium, Vascular | 4 | 2021 | 305 | 0.380 |
Why?
|
| Gene Deletion | 4 | 2020 | 116 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 243 | 0.350 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2021 | 104 | 0.350 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2021 | 28 | 0.340 |
Why?
|
| Humans | 17 | 2024 | 27067 | 0.340 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 129 | 0.330 |
Why?
|
| Carrier Proteins | 3 | 2006 | 246 | 0.320 |
Why?
|
| Animals, Newborn | 3 | 2020 | 177 | 0.300 |
Why?
|
| Erythropoiesis | 1 | 2007 | 9 | 0.300 |
Why?
|
| Retinal Vessels | 2 | 2020 | 71 | 0.290 |
Why?
|
| Erythrocytes | 2 | 2022 | 83 | 0.280 |
Why?
|
| Embryo Loss | 2 | 2020 | 2 | 0.250 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 2016 | 11 | 0.250 |
Why?
|
| Male | 11 | 2024 | 13003 | 0.240 |
Why?
|
| Fibrosis | 2 | 2024 | 121 | 0.240 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2024 | 1 | 0.240 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2024 | 10 | 0.240 |
Why?
|
| Talin | 1 | 2024 | 2 | 0.230 |
Why?
|
| Receptors, LDL | 1 | 2024 | 28 | 0.230 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2024 | 5 | 0.230 |
Why?
|
| Organogenesis | 1 | 2024 | 12 | 0.230 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2024 | 28 | 0.230 |
Why?
|
| Myeloid Cells | 1 | 2024 | 26 | 0.230 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2014 | 31 | 0.230 |
Why?
|
| Cell Adhesion | 1 | 2024 | 133 | 0.230 |
Why?
|
| Apoptosis | 3 | 2020 | 740 | 0.220 |
Why?
|
| Female | 10 | 2020 | 14613 | 0.220 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2024 | 91 | 0.220 |
Why?
|
| Up-Regulation | 2 | 2016 | 241 | 0.220 |
Why?
|
| Diabetic Angiopathies | 2 | 2014 | 48 | 0.220 |
Why?
|
| Integrases | 2 | 2017 | 39 | 0.210 |
Why?
|
| Morphogenesis | 3 | 2021 | 21 | 0.200 |
Why?
|
| Spermatogonia | 1 | 2022 | 2 | 0.200 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 156 | 0.200 |
Why?
|
| Adherens Junctions | 1 | 2022 | 8 | 0.200 |
Why?
|
| Indoles | 2 | 2020 | 98 | 0.200 |
Why?
|
| Inflammasomes | 1 | 2022 | 20 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 177 | 0.190 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 35 | 0.190 |
Why?
|
| Mitochondria | 1 | 2024 | 342 | 0.190 |
Why?
|
| Pregnancy | 3 | 2016 | 1148 | 0.190 |
Why?
|
| Cytokines | 1 | 2023 | 439 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2020 | 18 | 0.180 |
Why?
|
| Protein Transport | 3 | 2018 | 153 | 0.180 |
Why?
|
| Paclitaxel | 1 | 2021 | 184 | 0.180 |
Why?
|
| E-Selectin | 1 | 2020 | 27 | 0.170 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 44 | 0.170 |
Why?
|
| Down-Regulation | 3 | 2013 | 198 | 0.170 |
Why?
|
| Proteomics | 1 | 2021 | 177 | 0.170 |
Why?
|
| Thrombin | 1 | 2019 | 68 | 0.170 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Lymphangiogenesis | 2 | 2016 | 6 | 0.160 |
Why?
|
| Oxygen | 1 | 2020 | 230 | 0.160 |
Why?
|
| Fibronectins | 1 | 2018 | 28 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 2018 | 6 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 18 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 111 | 0.150 |
Why?
|
| Proprotein Convertases | 1 | 2018 | 11 | 0.150 |
Why?
|
| Immunoblotting | 1 | 2018 | 123 | 0.150 |
Why?
|
| Wound Healing | 3 | 2014 | 113 | 0.150 |
Why?
|
| Serum Response Factor | 1 | 2017 | 11 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2018 | 67 | 0.140 |
Why?
|
| Cadherins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Intercellular Junctions | 1 | 2017 | 8 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 105 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 262 | 0.140 |
Why?
|
| RNA Interference | 1 | 2017 | 135 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2016 | 119 | 0.140 |
Why?
|
| Gestational Age | 1 | 2017 | 141 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2017 | 134 | 0.140 |
Why?
|
| Transfection | 1 | 2017 | 313 | 0.130 |
Why?
|
| Binding Sites | 1 | 2017 | 341 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 364 | 0.130 |
Why?
|
| Genotype | 1 | 2017 | 443 | 0.130 |
Why?
|
| Hemostasis | 1 | 2016 | 47 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 331 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2016 | 264 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 66 | 0.130 |
Why?
|
| Inflammation | 1 | 2019 | 608 | 0.120 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 38 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Lymphatic System | 1 | 2014 | 11 | 0.120 |
Why?
|
| Lysosomes | 3 | 2018 | 55 | 0.110 |
Why?
|
| Thrombospondin 1 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 7 | 0.110 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2013 | 11 | 0.110 |
Why?
|
| Serpins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 54 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 46 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 116 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 47 | 0.100 |
Why?
|
| Anemia | 1 | 2012 | 41 | 0.100 |
Why?
|
| beta Catenin | 1 | 2012 | 62 | 0.100 |
Why?
|
| Sorting Nexins | 3 | 2006 | 6 | 0.090 |
Why?
|
| Frizzled Receptors | 1 | 2011 | 3 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2011 | 23 | 0.090 |
Why?
|
| Aging | 1 | 2018 | 951 | 0.090 |
Why?
|
| Lymphopoiesis | 1 | 2011 | 22 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 276 | 0.080 |
Why?
|
| Time Factors | 4 | 2014 | 1570 | 0.070 |
Why?
|
| Globins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Erythroblasts | 1 | 2007 | 3 | 0.070 |
Why?
|
| Receptor, TIE-2 | 1 | 2007 | 8 | 0.070 |
Why?
|
| Blood Cells | 1 | 2007 | 10 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2005 | 153 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2004 | 95 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2005 | 648 | 0.070 |
Why?
|
| Receptor, PAR-1 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cell Movement | 3 | 2014 | 353 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2006 | 116 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 112 | 0.060 |
Why?
|
| Hyaluronan Receptors | 1 | 2005 | 30 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 53 | 0.060 |
Why?
|
| Integrin alpha4beta1 | 1 | 2024 | 4 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2024 | 14 | 0.060 |
Why?
|
| Survival Rate | 1 | 2005 | 408 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2024 | 16 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 110 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 48 | 0.060 |
Why?
|
| Aorta | 1 | 2024 | 123 | 0.050 |
Why?
|
| Cell Death | 1 | 2023 | 111 | 0.050 |
Why?
|
| Monocytes | 1 | 2024 | 132 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2024 | 186 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 9 | 0.050 |
Why?
|
| Gonads | 1 | 2022 | 7 | 0.050 |
Why?
|
| Collagen | 2 | 2018 | 147 | 0.050 |
Why?
|
| Lipids | 1 | 2023 | 198 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 46 | 0.050 |
Why?
|
| Epothilones | 1 | 2021 | 5 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 280 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2014 | 774 | 0.050 |
Why?
|
| Rats | 2 | 2018 | 1554 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 398 | 0.040 |
Why?
|
| Endocytosis | 2 | 2014 | 81 | 0.040 |
Why?
|
| Mutation | 2 | 2018 | 818 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2023 | 635 | 0.040 |
Why?
|
| Mannosephosphates | 1 | 2018 | 5 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 26 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 31 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 20 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2018 | 26 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2018 | 29 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 77 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 131 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 115 | 0.040 |
Why?
|
| Homeostasis | 1 | 2018 | 115 | 0.040 |
Why?
|
| Naphthalenes | 1 | 2014 | 17 | 0.030 |
Why?
|
| Lymphedema | 1 | 2014 | 14 | 0.030 |
Why?
|
| Endosomes | 2 | 2006 | 44 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 36 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1099 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 55 | 0.030 |
Why?
|
| Lymph | 1 | 2014 | 5 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2006 | 206 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 122 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2014 | 8 | 0.030 |
Why?
|
| Lithium | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 168 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2014 | 97 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2014 | 40 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 31 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2006 | 195 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 283 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 345 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 87 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 285 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 112 | 0.030 |
Why?
|
| Zebrafish | 1 | 2014 | 95 | 0.030 |
Why?
|
| Gene Expression | 2 | 2006 | 408 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 455 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 140 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 448 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2011 | 11 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2011 | 9 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2011 | 45 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 445 | 0.020 |
Why?
|
| Antibodies | 1 | 2011 | 124 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 324 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 6 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 101 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2005 | 12 | 0.020 |
Why?
|
| Exons | 1 | 2005 | 41 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2005 | 44 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 229 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 205 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 118 | 0.010 |
Why?
|
| Transcription Factor TFIIIB | 1 | 2004 | 1 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2004 | 34 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2004 | 29 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 68 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 2005 | 95 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 60 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 64 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 110 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 408 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 589 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 546 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 133 | 0.010 |
Why?
|
| Fetal Viability | 1 | 2002 | 1 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2002 | 12 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 17 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 52 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 30 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 6882 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 636 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 163 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 7476 | 0.010 |
Why?
|